Disposition and protein binding of valproic acid in the developing rat

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Developmental Pharmacology
• Neuroscience

Background:

• Valproic acid (VPA) is a widely used antiepileptic drug with complex disposition.
• Understanding VPA pharmacokinetics in developing organisms is crucial for safe and effective dosing.
• Postnatal development significantly impacts drug metabolism and distribution.

Purpose of the Study:

• To investigate the age-dependent disposition of valproic acid (VPA) in developing rats.
• To characterize the changes in VPA serum and brain tissue concentrations, protein binding, and clearance during postnatal development.
• To explore the influence of development on VPA pharmacokinetic parameters and potential enterohepatic recirculation.

Main Methods:

• Determined VPA concentrations in serum and brain tissue of rats at postnatal days 5, 10, 20, and 60.
• Measured VPA serum protein binding ex vivo and in vitro using ultrafiltration across different age groups.
• Simultaneously fitted concentration-time data using pharmacokinetic models assuming first-order absorption and transfer.

Main Results:

• Total VPA clearance increased with postnatal age.
• Volume of distribution and brain-to-serum partitioning of VPA decreased during development.
• Serum protein binding of VPA progressively increased with postnatal development.
• Enterohepatic recirculation was not observed in pre-weaned animals.

Conclusions:

• VPA disposition undergoes significant maturation during rat postnatal development.
• Age-related changes in VPA pharmacokinetics, including clearance and protein binding, influence its distribution.
• The decreased brain-to-serum partitioning suggests reduced VPA penetration into the brain with maturation.